MAGNA LAB INC
NT 10-K, 1998-06-01
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: MAGNA LAB INC, 10KSB, 1998-06-01
Next: JEFFERSON SAVINGS BANCORP INC, 8-K, 1998-06-01






                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                                             Commission File Number  0-21320
                                             

                           NOTIFICATION OF LATE FILING

     (Check One):
     |X| Form 10-K |_| Form 11-K |_| Form 20-F |_| Form 10-Q |_| Form N-SAR

     For Period Ended: February 28, 1998

     |_| Transition Report on Form 10-K 
     |_| Transition Report on Form 20-F 
     |_| Transition Report on Form 11-K 
     |_| Transition Report on Form 10-Q 
     |_| Transition Report on Form N-SAR

     For the Transition Period Ended: ____________________

     Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

     If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
================================================================================


                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant  Magna-Lab Inc.
                         -------------------------------------------------------

Former name if applicable

- --------------------------------------------------------------------------------

Address of principal executive office (Street and number)
PO Box 780
- --------------------------------------------------------------------------------

City, state and zip code  Syosset, NY 11791
                          ------------------------------------------------------


                                     PART II
                             RULES 12b-25(b) AND (c)

     If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)

|X|       (a) The reasons described in reasonable detail in Part III of this
          form could not be eliminated without unreasonable effort or expense;

|X|       (b) The subject annual report, semi-annual report, transition report
          on Form 10-K, 20-F, 11-K or N-SAR, or portion thereof, will be filed
          on or before the 15th calendar day following the prescribed due date;
          or the subject quarterly report or transition report on Form 10-Q, or
          portion thereof will be filed on or before the fifth calendar day
          following the prescribed due date; and

|_|       (c) The accountant's statement or other exhibit required by Rule
          12b-25(c) has been attached if applicable.
<PAGE>

                                    PART III
                                    NARRATIVE

     State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q, N-SAR, or the transition report or portion thereof, could not be filed
within the prescribed time period.

     The Company had technical  difficulties  getting its completed  Form 10-KSB
     accepted  under the  electronic  EDGAR filing system prior to the 5:30 p.m.
     deadline  on May 29,  1998.  These  difficulties  were  unavoidable  as the
     Company   attempted  to  file  but  its  filing  was  not  accepted   until
     approximately  15  minutes  after the SEC  filing  deadline.  As such,  the
     Company expects that its timely  completed Form 10-KSB will be accepted for
     filing by the EDGAR system of the SEC on June 1, 1998.


                                     PART IV
                                OTHER INFORMATION

     (1) Name and telephone number of person to contact in regard to this
notification

Daniel M. Mulvena                                (516)        595-2111 
- --------------------------------------------------------------------------------
(Name)                                           (Area Code) (Telephone Number)


     (2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s).

                                                                  |X| Yes |_| No

     (3) Is it anticipated that any significant change in results of operation
for the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                                                  | | Yes |X| No

     If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.



                                 Magna-Lab Inc.
- - ------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date  June 1, 1998                    By /s/ Daniel M. Mulvena
      -------------                      ---------------------
                                      Name:  Daniel M. Mulvena
                                      Title: Chairman of the Board and
                                             Chief Executive Officer

          Instruction: The form may be signed by an executive officer of the
     registrant or by any other duly authorized representative. The name and
     title of the person signing the form shall be typed or printed beneath the
     signature. If the statement is signed on behalf of the registrant by an
     authorized representative (other than an executive officer), evidence of
     the representative's authority to sign on behalf of the registrant shall be
     filed with the form.

                                    ATTENTION
     Intentional misstatements or omissions of fact constitute Federal criminal
violations. (See 18 U.S.C. 1001)




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission